.
NOVO-B financial statements
* Numbers in billions
Year |
2021 | TTM |
---|---|---|
Capitalization * |
1 467 | 1 591 |
EV * |
1 483 | 1 483 |
Stock price ¤ |
638.9 | 692.6 |
Number of shares * |
2 | 2 |
EPS |
20,79 | 20,79 |
Revenue * |
141 | 141 |
Net income * |
48 | 48 |
Operating profit * |
59 | 59 |
Total liabilities * |
124 | 124 |
Net debt * |
16 | 16 |
Total assets * |
195 | 195 |
Equity * |
71 | 71 |
Cash and investments * |
17 | 17 |
Over the past 10 years, the maximum capitalization of Novo Nordisk A/S is 1 467, the minimum is 1 467. Maximum net income 48, Minimum net income 48. The maximum price of NOVO-B shares is 638.9, the minimum price is 638.9.
.
NOVO-B valuation
Year |
2021 | TTM |
---|---|---|
P/E |
30,72 | 33,31 |
P/B |
20,74 | 22,48 |
P/S |
10,42 | 11,30 |
E/P |
3% | 3% |
P/FCF |
30,82 | 33,41 |
.
NOVO-B profitability
Year |
2021 | TTM |
---|---|---|
ROE |
68% | |
ROA |
32% | |
ROIC |
62% |